Erbitux and White blood cell count decreased - from FDA reports


Summary

White blood cell count decreased is found among people who take Erbitux, especially for people who are male, 60+ old , have been taking the drug for < 1 month, also take medication Cisplatin, and have Lung cancer - non-small cell . We study 12,557 people who have side effects while taking Erbitux from FDA. Among them, 255 have White blood cell count decreased. Find out below who they are, when they have White blood cell count decreased and more.

What to expect?

If you take Erbitux and have White blood cell count decreased, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Erbitux and have White blood cell count decreased

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

Erbitux

Erbitux has active ingredients of cetuximab. It is often used in cancer. (latest outcomes from Erbitux 12,603 users)

White Blood Cell Count Decreased

White blood cell count decreased has been reported by people with hepatitis c, multiple myeloma, multiple sclerosis, schizophrenia, rheumatoid arthritis (latest reports from 54,926 White blood cell count decreased patients).

On Feb, 09, 2017

12,557 people reported to have side effects when taking Erbitux.
Among them, 255 people (2.03%) have White Blood Cell Count Decreased


Number of reports submitted per year:

Could Erbitux cause White blood cell count decreased?

Time on Erbitux when people have White Blood Cell Count Decreased *:

  • < 1 month: 72.31 %
  • 1 - 6 months: 26.15 %
  • 6 - 12 months: 1.54 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have White Blood Cell Count Decreased when taking Erbitux *:

  • female: 29.13 %
  • male: 70.87 %

Age of people who have White Blood Cell Count Decreased when taking Erbitux *:

  • 0-1: 0.0 %
  • 2-9: 0.85 %
  • 10-19: 0.42 %
  • 20-29: 0.0 %
  • 30-39: 0.85 %
  • 40-49: 2.97 %
  • 50-59: 23.31 %
  • 60+: 71.61 %

Top conditions involved for these people *:

  • Lung Cancer - Non-Small Cell (30 people, 11.76%)
  • Colon Cancer (26 people, 10.20%)
  • Oral Cancer (21 people, 8.24%)
  • Rectal Cancer (18 people, 7.06%)
  • Oesophageal Adenocarcinoma (16 people, 6.27%)

Top co-used drugs for these people *:

  • Cisplatin (89 people, 34.90%)
  • Taxol (74 people, 29.02%)
  • Carboplatin (57 people, 22.35%)
  • Decadron (25 people, 9.80%)
  • Polaramine (17 people, 6.67%)

Top other side effects for these people *:

  • Neutrophil Count Decreased (88 people, 34.51%)
  • Thrombocytopenia (85 people, 33.33%)
  • Dehydration (55 people, 21.57%)
  • Nausea (52 people, 20.39%)
  • Haemoglobin Decreased (49 people, 19.22%)

* Approximation only. Some reports may have incomplete information.

** Reports from social media are used.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have White blood cell count decreased when taking Erbitux?

Browse all side effects of Erbitux

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with White blood cell count decreased

White blood cell count decreased

Could your condition cause White blood cell count decreased

White blood cell count decreased

Related studies

You may be interested in these reviews

More reviews for: Erbitux, White blood cell count decreased